Janneke E. Jaspers
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
Papers in
- Oncology 12
- PARP inhibition in cancer therapy 7
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 1
-
- DNA Repair Mechanisms 6
- Genomics and Chromatin Dynamics 2
- Co-authors
- Sven Rottenberg (12 shared papers)Jos Jonkers (10 shared papers)Ariena Kersbergen (5 shared papers)Piet Borst (4 shared papers)Serge A.L. Zander (3 shared papers)Alan Lau (3 shared papers)Mark J. O’Connor (3 shared papers)Aaron Cranston (3 shared papers)
- Journals
- Cancer Research (5 papers)Molecular & Cellular Proteomics (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Cancer Therapeutics (1 paper)PLoS ONE (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Janneke E. Jaspers
17 papers receiving 2.1k citations
Janneke E. Jaspers's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 1.5k
- Molecular Biology 1.3k
- Cancer Research 254
- Reproductive Medicine 114
- Genetics 351
Countries citing papers authored by Janneke E. Jaspers
This map shows the geographic impact of Janneke E. Jaspers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janneke E. Jaspers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janneke E. Jaspers more than expected).
Fields of papers citing papers by Janneke E. Jaspers
This network shows the impact of papers produced by Janneke E. Jaspers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janneke E. Jaspers. The network helps show where Janneke E. Jaspers may publish in the future.
Co-authors
The 25 scholars most cited alongside Janneke E. Jaspers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Hit paper breakdown → | 2008 | 790 |
| 2 | 2012 | 398 | |
| 3 | 2010 | 145 | |
| 4 | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models Hit paper breakdown → | 2023 | 118 |
| 5 | 2015 | 103 | |
| 6 | 2017 | 88 | |
| 7 | 2010 | 86 | |
| 8 | 2010 | 69 | |
| 9 | 2016 | 60 | |
| 10 | 2013 | 59 | |
| 11 | 2014 | 55 | |
| 12 | 2009 | 32 | |
| 13 | 2013 | 25 | |
| 14 | 2012 | 24 | |
| 15 | 2016 | 15 | |
| 16 | 2014 | 14 | |
| 17 | 2010 | 1 |
About Janneke E. Jaspers
Janneke E. Jaspers is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), DNA Repair Mechanisms (6 papers), Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers), BRCA gene mutations in cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), CAR-T cell therapy research (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (1.3k citations), Cancer Research (254 citations), Reproductive Medicine (114 citations) and Genetics (351 citations). Janneke E. Jaspers has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Sven Rottenberg, Jos Jonkers, Ariena Kersbergen, Piet Borst, Serge A.L. Zander, Alan Lau, Mark J. O’Connor, Aaron Cranston, Niall M.B. Martin and Renier J. Brentjens. Their work appears in journals such as Cancer Research, Molecular & Cellular Proteomics, Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.